Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-003237
Filing Date
2025-03-19
Accepted
2025-03-19 06:45:31
Documents
97
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lqda-20241231x10k.htm   iXBRL 10-K 2338735
2 EX-10.25 lqda-20241231xex10d25.htm EX-10.25 87648
3 EX-10.53 lqda-20241231xex10d53.htm EX-10.53 16561
4 EX-21.1 lqda-20241231xex21d1.htm EX-21.1 3994
5 EX-23.1 lqda-20241231xex23d1.htm EX-23.1 4425
6 EX-31.1 lqda-20241231xex31d1.htm EX-31.1 14117
7 EX-31.2 lqda-20241231xex31d2.htm EX-31.2 13342
8 EX-32.1 lqda-20241231xex32d1.htm EX-32.1 6401
9 EX-32.2 lqda-20241231xex32d2.htm EX-32.2 6351
10 GRAPHIC lqda-20241231x10k001.jpg GRAPHIC 28042
  Complete submission text file 0001558370-25-003237.txt   10304247

Data Files

Seq Description Document Type Size
11 EX-101.SCH lqda-20241231.xsd EX-101.SCH 80625
12 EX-101.CAL lqda-20241231_cal.xml EX-101.CAL 72426
13 EX-101.DEF lqda-20241231_def.xml EX-101.DEF 249015
14 EX-101.LAB lqda-20241231_lab.xml EX-101.LAB 666448
15 EX-101.PRE lqda-20241231_pre.xml EX-101.PRE 457059
100 EXTRACTED XBRL INSTANCE DOCUMENT lqda-20241231x10k_htm.xml XML 1655634
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39724 | Film No.: 25750830
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)